Media Resources

Updates from Niowave

For Media Contact:
Liz Havey | lhavey@niowaveinc.com

Niowave, Inc. and Ratio Therapeutics Sign Supply Agreement for Actinium-225 to Advance Targeted Alpha Therapies

LANSING, MI and BOSTON, MA, June 16, 2026— Niowave, Inc., a leading manufacturer of medical...

50/50 strategic collaboration will develop up to three radiopharmaceutical programs. Innovation and investment continue to...

The new facility positions Niowave to meet global demand for Actinium‑225 and support growing pipeline...

Niowave has entered into a new agreement with Novartis to supply Actinium-225, a highly promising...

Lansing-based company reflects on two decades of innovation, evolving from equipment manufacturing to scaling next-generation...

Niowave will expand its agreement to supply Actinium-225, a highly promising medical isotope, to AstraZeneca

Reach out to the Niowave team